| 000 | 01621 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250518092909.0 | ||
| 264 | 0 | _c20210111 | |
| 008 | 202101s 0 0 eng d | ||
| 022 | _a1873-4367 | ||
| 024 | 7 |
_a10.1016/j.colsurfb.2020.110961 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHiga, Leticia Herminia | |
| 245 | 0 | 0 |
_aBacterioruberin from Haloarchaea plus dexamethasone in ultra-small macrophage-targeted nanoparticles as potential intestinal repairing agent. _h[electronic resource] |
| 260 |
_bColloids and surfaces. B, Biointerfaces _cJul 2020 |
||
| 300 |
_a110961 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
| 650 | 0 | 4 | _aCaco-2 Cells |
| 650 | 0 | 4 |
_aCarotenoids _xpharmacology |
| 650 | 0 | 4 |
_aDexamethasone _xpharmacology |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aGastrointestinal Tract _xdrug effects |
| 650 | 0 | 4 |
_aHalobacteriaceae _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation _xdrug therapy |
| 650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 |
_aNanoparticles _xadministration & dosage |
| 700 | 1 | _aSchilrreff, Priscila | |
| 700 | 1 | _aBriski, Andrés Martín | |
| 700 | 1 | _aJerez, Horacio Emanuel | |
| 700 | 1 | _ade Farias, Marcelo Alexandre | |
| 700 | 1 | _aVillares Portugal, Rodrigo | |
| 700 | 1 | _aRomero, Eder Lilia | |
| 700 | 1 | _aMorilla, Maria Jose | |
| 773 | 0 |
_tColloids and surfaces. B, Biointerfaces _gvol. 191 _gp. 110961 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.colsurfb.2020.110961 _zAvailable from publisher's website |
| 999 |
_c30776514 _d30776514 |
||